Blue Trust Inc. boosted its position in Avantor, Inc. (NYSE:AVTR – Free Report) by 6.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 8,069 shares of the company’s stock after purchasing an additional 522 shares during the quarter. Blue Trust Inc.’s holdings in Avantor were worth $170,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also added to or reduced their stakes in AVTR. MassMutual Private Wealth & Trust FSB increased its stake in shares of Avantor by 99.5% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company’s stock worth $26,000 after acquiring an additional 625 shares in the last quarter. UMB Bank n.a. bought a new position in shares of Avantor during the third quarter valued at approximately $49,000. Nisa Investment Advisors LLC lifted its holdings in shares of Avantor by 69.6% during the third quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company’s stock valued at $53,000 after purchasing an additional 835 shares during the last quarter. GAMMA Investing LLC lifted its holdings in shares of Avantor by 89.9% during the third quarter. GAMMA Investing LLC now owns 2,715 shares of the company’s stock valued at $70,000 after purchasing an additional 1,285 shares during the last quarter. Finally, Livforsakringsbolaget Skandia Omsesidigt boosted its position in shares of Avantor by 278.0% in the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 5,031 shares of the company’s stock worth $130,000 after purchasing an additional 3,700 shares in the last quarter. Hedge funds and other institutional investors own 95.08% of the company’s stock.
Wall Street Analyst Weigh In
A number of research analysts have issued reports on AVTR shares. Robert W. Baird lowered their price objective on Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a research note on Monday, October 28th. Wells Fargo & Company lowered their price target on Avantor from $30.00 to $28.00 and set an “overweight” rating for the company in a research report on Monday, October 28th. Barclays increased their price objective on shares of Avantor from $25.00 to $26.00 and gave the company an “overweight” rating in a research report on Monday. Raymond James decreased their target price on shares of Avantor from $29.00 to $26.00 and set an “outperform” rating for the company in a report on Tuesday, January 21st. Finally, UBS Group reiterated a “neutral” rating and set a $25.00 price target (down previously from $29.00) on shares of Avantor in a report on Friday, January 17th. Three investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $27.46.
Avantor Trading Up 0.7 %
NYSE:AVTR opened at $22.03 on Wednesday. The company has a 50 day simple moving average of $21.71 and a two-hundred day simple moving average of $23.47. The company has a market cap of $14.99 billion, a PE ratio of 47.88, a price-to-earnings-growth ratio of 3.97 and a beta of 1.28. The company has a current ratio of 1.54, a quick ratio of 1.06 and a debt-to-equity ratio of 0.84. Avantor, Inc. has a 12 month low of $19.59 and a 12 month high of $28.00.
About Avantor
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Featured Stories
- Five stocks we like better than Avantor
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- Why is the Ex-Dividend Date Significant to Investors?
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.